Hu23F2G humanized antibody: The IND was filed in December.

Icos Corp. (ICOS), Seattle Product: Hu23F2G humanized antibody Indication: Multiple sclerosis Status: The company said the expected first quarter start of its Phase I study has been delayed until the ...